급성 신손상(AKI) 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 이 기간에 예상되는 주요 동향은 웨어러블 투석 기기의 개발, 치료 최적화를 위한 인공지능의 통합, 휴대형 신 대체 요법 시스템의 발전, 지속적 신 대체 요법(CRRT)의 혁신, 원격 모니터링과 원격 의료 솔루션의 확대 등이 있습니다.
당뇨병의 유병률 증가는 급성 신손상(AKI) 시장의 확대를 촉진할 것으로 예측됩니다. 치명적인 라이프 스타일, 고령화, 인지도와 진단 능력의 향상 등의 요인에 의한 것입니다. 예를 들어, 2024년 3월 영국의 정부 부처인 건강 개선 및 격차 사무소는 2022년 3월부터 2023년 3월까지 1형 당뇨병 환자 중 8가지 권장 치료 과정을 모두 받은 비율이 22% 증가했으며, 2형 당뇨병의 경우 21% 증가했다고 보고했습니다. 이에 HbA1c의 목표치를 달성한 사람의 비율은 37.9%에 달하고, 전국 당뇨병 감사(NDA)가 기록한 가운데 가장 높은 수치가 되었습니다.
급성 신손상(AKI) 시장의 주요 기업은 제품 라인업의 확대와 신규 치료 솔루션의 도입을 위해 규제 당국의 승인을 우선하고 있습니다. 예를 들어, 2023년 12월 영국에 본사를 둔 생명공학 회사인 미션 테라퓨틱스는 심장 수술 후 고위험군 환자의 급성 신손상을 목표로 하는 주요 자산인 MTX652의 임상 2상 시험 개시를 위한 FDA의 승인을 받았습니다. MTX652의 특징은 AKI의 분자 원인에 대처하는 새로운 치료 메커니즘에 초점을 맞추는 것이며, 현재의 치료법에 비해 보다 효과적인 치료 옵션을 제공할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 급성 신손상(AKI) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 급성 신손상(AKI) 시장 : 성장률 분석
- 세계의 급성 신손상(AKI) 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 급성 신손상(AKI) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 급성 신손상(AKI) 전체 시장(TAM)
제6장 시장 세분화
- 세계의 급성 신손상(AKI) 시장 : 손상별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 신장 전 신손상
- 신장 후 신손상
- 내재성 신손상
- 세계의 급성 신손상(AKI) 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 투석
- 약물 치료
- 비뇨기 임플란트
- 세계의 급성 신손상(AKI) 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 외래수술센터(ASC)
- 기타 최종 사용자
- 세계의 급성 신손상(AKI) 시장 : 신장 전 신손상 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 저혈량증
- 심부전 관련 손상
- 패혈증으로 인한 손상
- 신장 동맥 협착증
- 간신증후군
- 세계의 급성 신손상(AKI) 시장 : 신장 후 신손상 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 요관 폐쇄
- 방광 배출구 폐쇄
- 전립선 비대증(양성 전립선 비대증)
- 신장 결석
- 요로에 영향을 미치는 종양
- 세계의 급성 신손상(AKI) 시장 : 내재성 신손상 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 급성 세뇨관 괴사(ATN)
- 급성 간질성 신염(AIN)
- 사구체신염
- 혈관염
- 횡문근융해증 유발 손상
제7장 지역별/국가별 분석
- 세계의 급성 신손상(AKI) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 급성 신손상(AKI) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 급성 신손상(AKI) 시장 : 경쟁 구도
- 급성 신손상(AKI) 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche Ltd 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Sanofi SA 개요, 제품 및 서비스, 전략 및 재무 분석
- Bristol-Myers Squibb Company 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Novartis AG
- Eli Lilly and Company
- Gilead Sciences Inc.
- Amgen Inc.
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Medical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Baxter International Inc.
- B. Braun Melsungen AG
- Nipro Corporation
- Nikkiso Co. Ltd.
- Quark Pharmaceuticals Inc.
- Kringle Pharma Inc.
- Aptabio Therapeutics Inc.
- Alexion Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 급성 신손상(AKI) 시장(2029년) : 새로운 기회를 제공하는 국가
- 급성 신손상(AKI) 시장(2029년) : 새로운 기회를 제공하는 부문
- 급성 신손상(AKI) 시장(2029년) : 성장 전략
제36장 부록
KTH
Acute kidney injury (AKI) is characterized by a sudden decline in kidney function, resulting in the buildup of waste products, electrolytes, and fluids within the body. It can develop within hours or days and is commonly triggered by factors such as reduced blood flow, direct kidney damage, or urinary tract obstruction.
The primary types of acute kidney injury include pre-renal, post-renal, and intrinsic kidney injury. Pre-renal kidney injury occurs due to a significant reduction in blood flow to the kidneys, leading to impaired filtration. Treatment options include dialysis, drug therapy, and urinary implants, serving end users such as hospitals, ambulatory surgical centers, and other healthcare facilities.
The acute kidney injury market research report is one of a series of new reports from The Business Research Company that provides acute kidney injury market statistics, including acute kidney injury industry global market size, regional shares, competitors with an acute kidney injury market share, detailed acute kidney injury market segments, market trends and opportunities, and any further data you may need to thrive in the acute kidney injury industry. This acute kidney injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The acute kidney injury market size has grown strongly in recent years. It will grow from $5.37 billion in 2024 to $5.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, growing incidence of hospital-acquired infections, increasing awareness about kidney health, and advancements in critical care medicine.
The acute kidney injury market size is expected to see strong growth in the next few years. It will grow to $7.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The projected growth during the forecast period is driven by the increasing incidence of sepsis, rising demand for personalized treatment, expanding government healthcare initiatives, growing healthcare expenditure in emerging markets, and a strong emphasis on personalized medicine and regenerative therapies. Key trends expected during this period include the development of wearable dialysis devices, the integration of artificial intelligence for treatment optimization, advancements in portable renal replacement therapy systems, innovations in continuous renal replacement therapy (CRRT), and the expansion of remote monitoring and telemedicine solutions.
The increasing prevalence of diabetes is expected to drive the expansion of the acute kidney injury (AKI) market. Diabetes encompasses a group of metabolic diseases characterized by elevated blood sugar levels, either due to insufficient insulin production or the body's inability to use insulin effectively. The rising incidence of diabetes is attributed to factors such as increasing obesity rates, poor dietary habits, sedentary lifestyles, aging populations, and improved awareness and diagnostic capabilities. Acute kidney injury induces metabolic and inflammatory changes that can impact insulin resistance and glucose regulation, creating a complex relationship that may affect diabetes management and progression. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the proportion of individuals achieving target HbA1c levels reached 37.9%, marking the highest figure ever recorded by the National Diabetes Audit (NDA). Consequently, the rising prevalence of diabetes is fueling the growth of the acute kidney injury market.
Leading companies in the acute kidney injury (AKI) market are prioritizing regulatory approvals to expand their product offerings and introduce novel treatment solutions. Regulatory approvals, granted by bodies such as the FDA or EMA, confirm that a product meets stringent safety, efficacy, and quality standards before entering the market. For instance, in December 2023, Mission Therapeutics Ltd., a UK-based biotechnology company, received FDA approval to initiate a Phase II clinical trial for its lead asset, MTX652, targeting acute kidney injury in high-risk patients following cardiac surgery. MTX652 is designed to target key pathways involved in kidney injury and repair, with the goal of reducing inflammation, preventing further kidney damage, and promoting recovery. A distinctive aspect of this trial is its focus on novel therapeutic mechanisms that address the molecular causes of AKI, potentially offering more effective treatment options compared to current interventions. The Phase II trial will assess MTX652's safety, efficacy, and pharmacokinetics, generating critical data that could support broader clinical use and eventual regulatory approval.
In July 2022, Terumo Blood and Cell Technologies, a US-based medical equipment manufacturer, partnered with Eliaz Therapeutics Inc. to develop an innovative therapeutic apheresis treatment for acute kidney injury (AKI) and sepsis-induced AKI (S-AKI). This treatment is designed to selectively remove the inflammatory protein Galectin-3 from blood plasma, with the objective of improving patient outcomes, reducing the risk of chronic kidney disease, and lowering hospital mortality rates. Eliaz Therapeutics Inc. is a US-based developer of medical devices specializing in innovative treatments for AKI and S-AKI.
Major players in the acute kidney injury market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co. Ltd., Teva Pharmaceutical Industries Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., Alexion Pharmaceuticals Inc., Alloksys Life Sciences B.V., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB.
North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acute kidney injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the acute kidney injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The acute kidney injury market includes revenues earned by entities by providing services such as urinalysis & biomarker testing, imaging services, dialysis services, and surgical & interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Acute Kidney Injury Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on acute kidney injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for acute kidney injury ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute kidney injury market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Injury: Pre-Renal Kidney Injury; Post-Renal Kidney Injury; Intrinsic Kidney Injury
- 2) By Treatment Type: Dialysis; Drug Therapy; Urinary Implants
- 3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
- Subsegments:
- 1) By Pre-Renal Kidney Injury: Hypovolemia; Heart Failure-Related Injury; Sepsis-Induced Injury; Renal Artery Stenosis; Hepatorenal Syndrome
- 2) By Post-Renal Kidney Injury: Ureteral Obstruction; Bladder Outlet Obstruction; Prostate Enlargement (Benign Prostatic Hyperplasia); Kidney Stones; Tumors Affecting Urinary Tract
- 3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN); Acute Interstitial Nephritis (AIN); Glomerulonephritis; Vasculitis; Rhabdomyolysis-Induced Injury
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Acute Kidney Injury Market Characteristics
3. Acute Kidney Injury Market Trends And Strategies
4. Acute Kidney Injury Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Acute Kidney Injury Growth Analysis And Strategic Analysis Framework
- 5.1. Global Acute Kidney Injury PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Acute Kidney Injury Market Growth Rate Analysis
- 5.4. Global Acute Kidney Injury Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Acute Kidney Injury Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Acute Kidney Injury Total Addressable Market (TAM)
6. Acute Kidney Injury Market Segmentation
- 6.1. Global Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pre-Renal Kidney Injury
- Post-Renal Kidney Injury
- Intrinsic Kidney Injury
- 6.2. Global Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dialysis
- Drug Therapy
- Urinary Implants
- 6.3. Global Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Other End Users
- 6.4. Global Acute Kidney Injury Market, Sub-Segmentation Of Pre-Renal Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypovolemia
- Heart Failure-Related Injury
- Sepsis-Induced Injury
- Renal Artery Stenosis
- Hepatorenal Syndrome
- 6.5. Global Acute Kidney Injury Market, Sub-Segmentation Of Post-Renal Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ureteral Obstruction
- Bladder Outlet Obstruction
- Prostate Enlargement (Benign Prostatic Hyperplasia)
- Kidney Stones
- Tumors Affecting Urinary Tract
- 6.6. Global Acute Kidney Injury Market, Sub-Segmentation Of Intrinsic Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute Tubular Necrosis (ATN)
- Acute Interstitial Nephritis (AIN)
- Glomerulonephritis
- Vasculitis
- Rhabdomyolysis-Induced Injury
7. Acute Kidney Injury Market Regional And Country Analysis
- 7.1. Global Acute Kidney Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Acute Kidney Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Acute Kidney Injury Market
- 8.1. Asia-Pacific Acute Kidney Injury Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Acute Kidney Injury Market
- 9.1. China Acute Kidney Injury Market Overview
- 9.2. China Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Acute Kidney Injury Market
- 10.1. India Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Acute Kidney Injury Market
- 11.1. Japan Acute Kidney Injury Market Overview
- 11.2. Japan Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Acute Kidney Injury Market
- 12.1. Australia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Acute Kidney Injury Market
- 13.1. Indonesia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Acute Kidney Injury Market
- 14.1. South Korea Acute Kidney Injury Market Overview
- 14.2. South Korea Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Acute Kidney Injury Market
- 15.1. Western Europe Acute Kidney Injury Market Overview
- 15.2. Western Europe Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Acute Kidney Injury Market
- 16.1. UK Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Acute Kidney Injury Market
- 17.1. Germany Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Acute Kidney Injury Market
- 18.1. France Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Acute Kidney Injury Market
- 19.1. Italy Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Acute Kidney Injury Market
- 20.1. Spain Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Acute Kidney Injury Market
- 21.1. Eastern Europe Acute Kidney Injury Market Overview
- 21.2. Eastern Europe Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Acute Kidney Injury Market
- 22.1. Russia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Acute Kidney Injury Market
- 23.1. North America Acute Kidney Injury Market Overview
- 23.2. North America Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Acute Kidney Injury Market
- 24.1. USA Acute Kidney Injury Market Overview
- 24.2. USA Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Acute Kidney Injury Market
- 25.1. Canada Acute Kidney Injury Market Overview
- 25.2. Canada Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Acute Kidney Injury Market
- 26.1. South America Acute Kidney Injury Market Overview
- 26.2. South America Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Acute Kidney Injury Market
- 27.1. Brazil Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Acute Kidney Injury Market
- 28.1. Middle East Acute Kidney Injury Market Overview
- 28.2. Middle East Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Acute Kidney Injury Market
- 29.1. Africa Acute Kidney Injury Market Overview
- 29.2. Africa Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Acute Kidney Injury Market Competitive Landscape And Company Profiles
- 30.1. Acute Kidney Injury Market Competitive Landscape
- 30.2. Acute Kidney Injury Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Acute Kidney Injury Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Eli Lilly and Company
- 31.3. Gilead Sciences Inc.
- 31.4. Amgen Inc.
- 31.5. Fresenius Medical Care AG & Co. KGaA
- 31.6. Asahi Kasei Medical Co. Ltd.
- 31.7. Teva Pharmaceutical Industries Ltd.
- 31.8. Baxter International Inc.
- 31.9. B. Braun Melsungen AG
- 31.10. Nipro Corporation
- 31.11. Nikkiso Co. Ltd.
- 31.12. Quark Pharmaceuticals Inc.
- 31.13. Kringle Pharma Inc.
- 31.14. Aptabio Therapeutics Inc.
- 31.15. Alexion Pharmaceuticals Inc.
32. Global Acute Kidney Injury Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Acute Kidney Injury Market
34. Recent Developments In The Acute Kidney Injury Market
35. Acute Kidney Injury Market High Potential Countries, Segments and Strategies
- 35.1 Acute Kidney Injury Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Acute Kidney Injury Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Acute Kidney Injury Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
